ISG revenues soar to new heights

Article

Sales of diagnostic imaging software to several large medical-device customers and a rise in licensing fees helped boost fourth-quarter and year-end financials to record levels for ISG Technologies. The Toronto-based medical-imaging software developer

Sales of diagnostic imaging software to several large medical-device customers and a rise in licensing fees helped boost fourth-quarter and year-end financials to record levels for ISG Technologies. The Toronto-based medical-imaging software developer reported a 30% increase in revenues and a 250% increase in earnings for its fiscal year (end-June 30). Revenues were $32 million (U.S.) in fiscal 1999, up from $24.3 million in fiscal 1998. The company had earnings of $1.2 million, compared with $336,500 last year. Revenues for the quarter were $9.8 million, compared with $6.8 million for the fourth quarter a year ago. Profits for the quarter were $608,000, compared with $135,000 for the same period in 1998.

ISG realized earnings increases in all three of its business units (image management, diagnostic imaging, and image-guided surgery), plus a 62% rise in software license fee generation, according to CEO Michael Greenberg. The enhanced penetration of ISG’s Image Application Platform software in healthcare accounts for the increase in licensing fees, according to ISG.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.